91 related articles for article (PubMed ID: 26192610)
1. Terminal restriction fragment polymorphism analyses of fecal microbiota in five siblings including two with ulcerative colitis.
Andoh A; Ida S; Tsujikawa T; Benno Y; Fujiyama Y
Clin J Gastroenterol; 2009 Oct; 2(5):343-345. PubMed ID: 26192610
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.
Andoh A; Imaeda H; Aomatsu T; Inatomi O; Bamba S; Sasaki M; Saito Y; Tsujikawa T; Fujiyama Y
J Gastroenterol; 2011 Apr; 46(4):479-86. PubMed ID: 21253779
[TBL] [Abstract][Full Text] [Related]
3. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis.
Andoh A; Sakata S; Koizumi Y; Mitsuyama K; Fujiyama Y; Benno Y
Inflamm Bowel Dis; 2007 Aug; 13(8):955-62. PubMed ID: 17455205
[TBL] [Abstract][Full Text] [Related]
4. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
Nishikawa J; Kudo T; Sakata S; Benno Y; Sugiyama T
Scand J Gastroenterol; 2009; 44(2):180-6. PubMed ID: 18825588
[TBL] [Abstract][Full Text] [Related]
5. Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.
Nemoto H; Kataoka K; Ishikawa H; Ikata K; Arimochi H; Iwasaki T; Ohnishi Y; Kuwahara T; Yasutomo K
Dig Dis Sci; 2012 Nov; 57(11):2955-64. PubMed ID: 22623042
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
7. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
[TBL] [Abstract][Full Text] [Related]
8. Bacterial immune interaction in experimental colitis.
Xue LY; Ouyang Q; Zhou XG; Huang ZH; Chen W; Chen M; Yu LM
J Dig Dis; 2013 Oct; 14(10):526-35. PubMed ID: 23734583
[TBL] [Abstract][Full Text] [Related]
9. Identification of bacteria from blood in febrile patients with ulcerative colitis by terminal restriction fragment length polymorphism profile analysis of 16S rRNA gene.
Harada A; Ohkusa T; Kushima K; Sakamoto M; Benno Y; Beppu K; Shibuya T; Sakamoto N; Watanabe S
Scand J Gastroenterol; 2008; 43(4):423-30. PubMed ID: 18365907
[TBL] [Abstract][Full Text] [Related]
10. [Application of particular human fecal microbiota profile for disease precaution].
Benno Y
Rinsho Byori; 2004 May; 52(5):440-7. PubMed ID: 15206132
[TBL] [Abstract][Full Text] [Related]
11. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
[TBL] [Abstract][Full Text] [Related]
12. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
Chen WX; Ren LH; Shi RH
World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
[TBL] [Abstract][Full Text] [Related]
13. [Terminal-restriction fragment length polymorphism analysis of diversity of mucosa-associated microbiota in patients with Crohn's disease].
Ran WB; Ouyang Q; Shi W
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2884-9. PubMed ID: 24373401
[TBL] [Abstract][Full Text] [Related]
14. Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.
Zhang SL; Wang SN; Miao CY
Front Immunol; 2017; 8():1674. PubMed ID: 29234327
[TBL] [Abstract][Full Text] [Related]
15. Comparison between terminal-restriction fragment length polymorphism (T-RFLP) and quantitative culture for analysis of infants' gut microbiota.
Sjöberg F; Nowrouzian F; Rangel I; Hannoun C; Moore E; Adlerberth I; Wold AE
J Microbiol Methods; 2013 Jul; 94(1):37-46. PubMed ID: 23583598
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota in pouchitis and ulcerative colitis.
Li KY; Wang JL; Wei JP; Gao SY; Zhang YY; Wang LT; Liu G
World J Gastroenterol; 2016 Oct; 22(40):8929-8939. PubMed ID: 27833384
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
[TBL] [Abstract][Full Text] [Related]
18. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.
De Leon LM; Watson JB; Kelly CR
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1036-8. PubMed ID: 23669309
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of fecal microbiota transplantation.
Smits LP; Bouter KE; de Vos WM; Borody TJ; Nieuwdorp M
Gastroenterology; 2013 Nov; 145(5):946-53. PubMed ID: 24018052
[TBL] [Abstract][Full Text] [Related]
20. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens.
Falk A; Olsson C; Ahrné S; Molin G; Adawi D; Jeppsson B
Scand J Gastroenterol; 2007 Aug; 42(8):973-85. PubMed ID: 17613928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
